Results 21 to 30 of about 21,405,282 (107)

Lectura palimpsestuosa de Josep Palau i Fabre, logófago [PDF]

open access: yes, 2020
Amongst the figures of logophagy that Túa Blesa puts forward in his remarkable Logografías (1998), there is the text-apsis. The article states that «L’aventura», by Josep Palau i Fabre, a sequence of five poems of eight lines each, is a text-apsis ...
Sullà, Enric
core   +1 more source

El mimetismo femenino en la obra narrativa de Josep Palau i Fabre

open access: yesConfluenze, 2017
The notion of mimesis proposed by the Catalan writer Josep Palau i Fabre must be closely related to the disintegration of the self and also to a process of alienation of identity, fundamental concepts of his literary work.
Anna Perera Roura
doaj   +1 more source

Shakespeare in Josep Palau i Fabre [PDF]

open access: yes, 2020
William Shakespeare és un escriptor que va tenir una gran importància en la trajectòria vital i literària de Josep Palau i Fabre.
Malé Pegueroles, Jordi
core  

El laberint del jo. Fonaments per a la interpretació del primer teatre de Josep Palau i Fabre (1935 – 1958) [PDF]

open access: yes, 2012
La tesi de doctorat El laberint del jo: Fonaments per a la interpretació del primer teatre de Josep Palau i Fabre (1935 – 1958) –dirigida pel doctor Jaume Mascaró i amb el suport tutoral del doctor Francesc Foguet–, es basa en els canvis conceptuals que ...
Coca Villalonga, Jordi
core   +3 more sources

Palau i Fabre i Itàlia

open access: yes, 2019
Aquest estudi se centra, d'una banda, en les relacions de Palau i Fabre amb la literatura, l'art i la cultura italianes; i, de l'altra, en la recepció (molt limitada) de la seva ...
Francesco Ardolino
core   +1 more source

Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Systemic treatment of cutaneous melanoma has changed since 2011, with clinical studies demonstrating improved outcomes. This analysis evaluated whether this improvement is evident in a real‐world cohort, focusing on overall survival (OS) and relapse‐free survival (RFS).
Lena Nanz   +7 more
wiley   +1 more source

Long‐term efficacy of biologics in moderate‐to‐severe hidradenitis suppurativa: A systematic review and MAIC

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
A matching‐adjusted indirect treatment comparison (MAIC) was conducted, comparing approved biologics for long‐term (48–52 weeks) treatment of moderate‐to‐severe hidradenitis suppurativa (HS). Using weighted patient‐level trial data allowed re‐estimation of relative bimekizumab efficacy compared with aggregate secukinumab and adalimumab trial data ...
Thrasyvoulos Tzellos   +9 more
wiley   +1 more source

Una revisión de Josep Palau i Fabre, dramaturgo [PDF]

open access: yes, 2012
Josep Palau i Fabre (Barcelona, ​​1917-2008), poeta, narrador, ensayista y dramaturgo, es considerado uno de los máximos expertos internacionales sobre la obra y la personalidad de Picasso.
Coca, Jordi
core   +1 more source

European S2k guidelines for hidradenitis suppurativa/acne inversa Part 1. Epidemiology, diagnosis and clinical assessment

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Updated S2k hidradenitis suppurativa (HS) guidelines provide expert consensus on diagnosis, assessment and comorbidities. Expanded substantially since the 2015 version, they reflect rapid growth in HS literature and aim to improve generalist‐level patient care through evidence‐informed, consensus‐based guidance.
G. B. E. Jemec   +36 more
wiley   +1 more source

Cancer survivorship in malignant melanoma

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 9, Page e1291-e1308, September 2026.
Summary Robust long‐term survival data have transformed the prognosis of metastatic melanoma. For combination therapy with immune checkpoint inhibitors (ICIs), 10‐year melanoma‐specific survival rates now exceed 50 %, and durable disease control is achievable in a substantial proportion of patients, including those with brain metastases.
Markus Reitmajer   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy